Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?
Sign Up to like & getrecommendations! Published in 2019 at "Current pharmaceutical design"
DOI: 10.2174/1381612825666190307165703
Abstract: Inflammatory Bowel Disease is lifetime chronic progressive inflammatory disease. A considerable portion of patients, do not respond or lose response or experience side effect to "traditional" biological treatment such as anti-tumor necrosis factor (TNF)-α agents.… read more here.
Keywords: molecules ibd; anti adhesion; adhesion molecules; gut selectivity ... See more keywords